227 related articles for article (PubMed ID: 17569411)
1. Treatment of patients with substance use disorders, second edition. American Psychiatric Association.
Kleber HD; Weiss RD; Anton RF; George TP; Greenfield SF; Kosten TR; O'Brien CP; Rounsaville BJ; Strain EC; Ziedonis DM; Hennessy G; Connery HS; McIntyre JS; Charles SC; Anzia DJ; Cook IA; Finnerty MT; Johnson BR; Nininger JE; Summergrad P; Woods SM; Yager J; Pyles R; Cross CD; Peele R; Shemo JP; Lurie L; Walker RD; Barnovitz MA; Gray SH; Saxena S; Tonnu T; Kunkle R; Albert AB; Fochtmann LJ; Hart C; Regier D; ; ;
Am J Psychiatry; 2007 Apr; 164(4 Suppl):5-123. PubMed ID: 17569411
[No Abstract] [Full Text] [Related]
2. A meta-analytic review of psychosocial interventions for substance use disorders.
Dutra L; Stathopoulou G; Basden SL; Leyro TM; Powers MB; Otto MW
Am J Psychiatry; 2008 Feb; 165(2):179-87. PubMed ID: 18198270
[TBL] [Abstract][Full Text] [Related]
3. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with substance use disorders, second edition. American Psychiatic Association.
; Kleber HD; Weiss RD; Anton RF; Rounsaville BJ; George TP; Strain EC; Greenfield SF; Ziedonis DM; Kosten TR; Hennessy G; O'Brien CP; Connery HS; ; McIntyre JS; Charles SC; Anzia DJ; Nininger JE; Cook IA; Summergrad P; Finnerty MT; Woods SM; Johnson BR; Yager J; Pyles R; Lurie L; Cross CD; Walker RD; Peele R; Barnovitz MA; Gray SH; Shemo JP; Saxena S; Tonnu T; Kunkle R; Albert AB; Fochtmann LJ; Hart C; Regier D
Am J Psychiatry; 2006 Aug; 163(8 Suppl):5-82. PubMed ID: 16981488
[No Abstract] [Full Text] [Related]
5. An empirical perspective on cigarette use in substance use recovery.
Goodwin RD; Wu M; Davidson L
Psychol Med; 2021 Oct; 51(14):2299-2306. PubMed ID: 34261564
[No Abstract] [Full Text] [Related]
6. [Interdisciplinary therapeutic approaches with substance abusers taking into consideration gender differences].
Fischer G; Eder H
Wien Med Wochenschr; 1999; 149(11):331-6. PubMed ID: 10544458
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies for adolescent substance use disorders.
Simkin DR; Grenoble S
Child Adolesc Psychiatr Clin N Am; 2010 Jul; 19(3):591-608. PubMed ID: 20682223
[TBL] [Abstract][Full Text] [Related]
8. Profiles of drug use behavior change for adolescents in treatment.
Waldron HB; Turner CW; Ozechowski TJ
Addict Behav; 2005 Oct; 30(9):1775-96. PubMed ID: 16202539
[TBL] [Abstract][Full Text] [Related]
9. [Tobacco use and illicit substance use disorders: what should we have to do?].
Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
[TBL] [Abstract][Full Text] [Related]
10. [Levels of evidence in drug therapy for alcohol use disorders and illicit drug use].
Burucker J; Kropp S
Fortschr Neurol Psychiatr; 2012 Dec; 80(12):684-93. PubMed ID: 23229101
[TBL] [Abstract][Full Text] [Related]
11. Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women.
Meinhofer A; Witman A; Murphy SM; Bao Y
Addiction; 2019 Sep; 114(9):1593-1601. PubMed ID: 31106499
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
van den Brink W
Curr Drug Abuse Rev; 2012 Mar; 5(1):3-31. PubMed ID: 22126708
[TBL] [Abstract][Full Text] [Related]
13. Cocaine abuse during pregnancy: psychiatric considerations.
James ME; Coles CD
Gen Hosp Psychiatry; 1991 Nov; 13(6):399-409. PubMed ID: 1765257
[TBL] [Abstract][Full Text] [Related]
14. [The endogenous opioid system and drug addiction].
Maldonado R
Ann Pharm Fr; 2010 Jan; 68(1):3-11. PubMed ID: 20176158
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy: Quest for the quitting pill.
Willyard C
Nature; 2015 Jun; 522(7557):S53-5. PubMed ID: 26107096
[No Abstract] [Full Text] [Related]
16. Does treatment readiness enhance the response of African American substance users to Motivational Enhancement Therapy?
Burlew AK; Montgomery L; Kosinski AS; Forcehimes AA
Psychol Addict Behav; 2013 Sep; 27(3):744-53. PubMed ID: 23421576
[TBL] [Abstract][Full Text] [Related]
17. Characterizing pregnant drug-dependent women in treatment and their children.
Kissin WB; Svikis DS; Morgan GD; Haug NA
J Subst Abuse Treat; 2001 Jul; 21(1):27-34. PubMed ID: 11516924
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
Shinn AK; Greenfield SF
J Clin Psychiatry; 2010 May; 71(5):634-48. PubMed ID: 20361908
[TBL] [Abstract][Full Text] [Related]
19. Treatment studies involving adolescents with drug and alcohol disorders.
Cornelius JR
Addict Behav; 2005 Oct; 30(9):1627-9. PubMed ID: 16209906
[No Abstract] [Full Text] [Related]
20. The integration of pharmacotherapy and nonpharmacotherapy.
Miller NS; Smith DE
J Addict Dis; 1997; 16(4):51-64. PubMed ID: 9328809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
